CONSIDERATIONS AND EXPERIENCES FROM TAKING A FULLY PERSONALIZED TARGETED CANCER NEOANTIGEN DNA VACCINE INTO THE CLINIC | London, October 2019
1915
portfolio_page-template-default,single,single-portfolio_page,postid-1915,bridge-core-1.0.4,ajax_updown_fade,page_not_loaded,,qode-title-hidden,qode-child-theme-ver-,qode-theme-ver-18.2.1,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,wpb-js-composer js-comp-ver-6.0.5,vc_responsive

CONSIDERATIONS AND EXPERIENCES FROM TAKING A FULLY PERSONALIZED TARGETED CANCER NEOANTIGEN DNA VACCINE INTO THE CLINIC

London, 10 October 2019